EU/US/Canada pool resources to study genetic mutations:
This article was originally published in Clinica
Executive Summary
The European Commission, the US National Institutes of Health and Genome Canada are taking part in a Euro56.5m ($72m) global collaborative research programme designed to lead to better understanding of the genetic make-up of human diseases. Of this amount, Euro13m will be contributed from the EU's Research Framework Programme. The programme will study the activity of genes in mice (mice and humans share 99% of their genetic make-up), using a process that "knocks out" specific genes. The information on mutations in the mouse genome generated by the programme will be freely accessible to the scientific community, constituting a significant resource to help translate basic research in to improvements in human health.
You may also be interested in...
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.